HMGB1 and ovarian benign neoplasm: The presence of circulating HMGB1 in patients with ovarian cancer has been reported, and the levels were significantly higher than those in patients with benign ovarian tumors or healthy donors, and the levels in recurrent patients were higher than those in nonrecurrent patients [19, 20].